Engineered Protein Photo-Thermal Hydrogels for Outstanding In Situ Tongue Cancer Therapy

Juanjuan Su1,2, Shuang Lu1, Shengjie Jiang3

  • 1State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.

Insights

A novel injectable hydrogel offers a new treatment for tongue cancer. This near-infrared light-activated therapy effectively destroys tumors with no harm to healthy tissue, preventing recurrence.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Oncology

Background:

  • Surgical excision is the primary treatment for tongue cancer, but often leads to functional deficits and high recurrence rates.
  • There is an urgent need for alternative therapeutic strategies for oral cancers.
  • Current treatments can cause severe impairment to oral and maxillofacial functions.

Purpose of the Study:

  • To develop an alternative tongue cancer therapy using a novel biomaterial.
  • To investigate the efficacy of a near-infrared (NIR) light-responsive hydrogel for photothermal therapy (PTT).
  • To evaluate the biocompatibility and therapeutic potential of the hydrogel in an in situ tongue tumor model.

Main Methods:

  • Fabrication of a NIR light-responsive, peritumoral injectable hydrogel.
  • Incorporation of Ag3AuS2 nanoparticles (NPs) within a protein and chitosan network.
  • Evaluation of hydrogel biocompatibility and photothermal effect.
  • Assessment of tumor eradication, side effects, and recurrence inhibition in an in situ tongue tumor model.

Main Results:

  • The hydrogel demonstrated good biocompatibility and a strong photothermal effect.
  • A single PTT treatment using the hydrogel efficiently eradicated tumors in the in situ model.
  • No adverse side effects were observed in surrounding normal tissues.
  • The treatment successfully inhibited potential tumor recurrence.

Conclusions:

  • The developed NIR-responsive hydrogel is a promising alternative to surgical excision for tongue cancer.
  • This injectable biomaterial offers effective in situ tumor eradication with minimal side effects.
  • The strategy holds significant potential for the clinical treatment of oral cancers.

Related Concept Videos